Page last updated: 2024-11-02

1,7-dimethylxanthine and Chronic Hepatitis

1,7-dimethylxanthine has been researched along with Chronic Hepatitis in 1 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Research Excerpts

Excerpt	Relevance	Reference
"Subjects with liver cirrhosis and chronic hepatitis, as well as healthy volunteers, were given the oral dose of 300 mg caffeine."	2.71	Serum metabolite/caffeine ratios as a test for liver function. ( Flieger, J; Jodynis-Liebert, J; Juszczyk, J; Matuszewska, A, 2004)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jodynis-Liebert, J	1
Flieger, J	1
Matuszewska, A	1
Juszczyk, J	1

Clinical Trials (1)

Trial Overview

Trial			Phase	Enrollment	Study Type	Start Date	Status
Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569]			Phase 3	120 participants (Anticipated)	Interventional	2005-09-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 1,7-dimethylxanthine and Chronic Hepatitis

Article	Year
Serum metabolite/caffeine ratios as a test for liver function. Journal of clinical pharmacology, 2004, Volume: 44, Issue:4 Topics: Adult; Caffeine; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; M	2004